|
|
|
|
RS Magliozzo, J Peisach and MR Ciriolo
Department of Molecular Pharmacology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461.
Activated bleomycin is shown for the first time to cleave tRNA in a specific and dose-dependent manner. Adenine and uracil are released in the reaction. Bleomycin and Fe(III)-bleomycin bind to yeast tRNAPhe) in analogy with the known behavior of the drug with B-DNA.
This article has been cited by other articles:
![]() |
J. W. Sam, S. Takahashi, I. Lippai, J. Peisach, and D. L. Rousseau Sequence-specific Changes in the Metal Site of Ferric Bleomycin Induced by the Binding of DNA J. Biol. Chem., June 26, 1998; 273(26): 16090 - 16097. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maruyama, T. Kumagai, Y. Matoba, M. Hayashida, T. Fujii, Y. Hata, and M. Sugiyama Crystal Structures of the Transposon Tn5-carried Bleomycin Resistance Determinant Uncomplexed and Complexed with Bleomycin J. Biol. Chem., March 23, 2001; 276(13): 9992 - 9999. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sugiyama, T. Kumagai, M. Hayashida, M. Maruyama, and Y. Matoba The 1.6-A Crystal Structure of the Copper(II)-bound Bleomycin Complexed with the Bleomycin-binding Protein from Bleomycin-producing Streptomyces verticillus J. Biol. Chem., January 11, 2002; 277(3): 2311 - 2320. [Abstract] [Full Text] [PDF] |
||||